Stay updated on CAR-T for CD33+ AML Clinical Trial

Sign up to get notified when there's something new on the CAR-T for CD33+ AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CAR-T for CD33+ AML Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s revision/build label was updated from v3.5.2 to v3.5.3, indicating a software or site version change rather than a modification to the clinical trial information.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:50.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    - Revision metadata updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T06:12:22.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the page header.
    Difference
    0.1%
    Check dated 2026-03-12T02:31:12.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the older v3.4.1 funding/operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T13:59:17.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    Added a site-wide notice about government funding status and an updated version reference (Revision: v3.4.1). Removed the previous Revision: v3.4.0.
    Difference
    0.4%
    Check dated 2026-02-04T10:15:21.000Z thumbnail image

Stay in the know with updates to CAR-T for CD33+ AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CAR-T for CD33+ AML Clinical Trial page.